InvestorsHub Logo
Followers 125
Posts 5429
Boards Moderated 0
Alias Born 06/09/2020

Re: Hopeforthefuture3 post# 476926

Saturday, 05/21/2022 11:31:38 AM

Saturday, May 21, 2022 11:31:38 AM

Post# of 705742
Merck should ignore NWBO and try their luck with another P1 immunology treatment in order to save money.

I'm sure they will love the outcome of DCVax-L being engaged with Nivolumab instead.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News